BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 17965864)

  • 1. [Interdisciplinary consensus to management of lupus nephritis in Germany].
    de Groot K
    Z Rheumatol; 2007 Dec; 66(8):724, 726. PubMed ID: 17965864
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of proliferative lupus nephritis: a changing landscape.
    Adu D
    Kidney Int; 2006 Aug; 70(4):616-8. PubMed ID: 16900218
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of lupus nephritis: art or science?
    Endre Z
    Intern Med J; 2001 Jul; 31(5):264-6. PubMed ID: 11512596
    [No Abstract]   [Full Text] [Related]  

  • 4. Treatment of lupus nephritis--a work in progress.
    Falk RJ
    N Engl J Med; 2000 Oct; 343(16):1182-3. PubMed ID: 11036127
    [No Abstract]   [Full Text] [Related]  

  • 5. Sequential therapies for proliferative lupus nephritis.
    Contreras G; Pardo V; Leclercq B; Lenz O; Tozman E; O'Nan P; Roth D
    N Engl J Med; 2004 Mar; 350(10):971-80. PubMed ID: 14999109
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sequential therapies for proliferative lupus nephritis.
    Farhey Y; Hess E
    N Engl J Med; 2004 Jun; 350(24):2518-20; author reply 2518-20. PubMed ID: 15195342
    [No Abstract]   [Full Text] [Related]  

  • 7. Maintenance therapy for lupus nephritis--something old, something new.
    Balow JE; Austin HA
    N Engl J Med; 2004 Mar; 350(10):1044-6. PubMed ID: 14999117
    [No Abstract]   [Full Text] [Related]  

  • 8. Sequential therapies for proliferative lupus nephritis.
    Gelber AC; Christopher-Stine L; Fine DM
    N Engl J Med; 2004 Jun; 350(24):2518-20; author reply 2518-20. PubMed ID: 15195341
    [No Abstract]   [Full Text] [Related]  

  • 9. Azathioprine/methylprednisolone versus cyclophosphamide in proliferative lupus nephritis. A randomized controlled trial.
    Grootscholten C; Ligtenberg G; Hagen EC; van den Wall Bake AW; de Glas-Vos JW; Bijl M; Assmann KJ; Bruijn JA; Weening JJ; van Houwelingen HC; Derksen RH; Berden JH;
    Kidney Int; 2006 Aug; 70(4):732-42. PubMed ID: 16820790
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Celebrating the ACP centennial: from the Annals archive.
    Cotton D
    Ann Intern Med; 2015 Jan; 162(1):70. PubMed ID: 25560715
    [No Abstract]   [Full Text] [Related]  

  • 11. Induction therapy for active lupus nephritis: mycophenolate mofetil versus cyclophosphamide.
    Burchardi C; Schlöndorff D
    Nat Clin Pract Nephrol; 2006 Jun; 2(6):314-5. PubMed ID: 16932452
    [No Abstract]   [Full Text] [Related]  

  • 12. [Mycophenolate mofetil in lupus nephritis treatment].
    Savio V; Alba P; Babini AM
    Rev Fac Cien Med Univ Nac Cordoba; 2012; 69(4):219-23. PubMed ID: 23751789
    [No Abstract]   [Full Text] [Related]  

  • 13. How did cyclophosphamide become the drug of choice for lupus nephritis?
    Bargman JM
    Nephrol Dial Transplant; 2009 Feb; 24(2):381-4. PubMed ID: 19056783
    [No Abstract]   [Full Text] [Related]  

  • 14. New and future therapies for lupus nephritis.
    Appel GB
    Cleve Clin J Med; 2012 Feb; 79(2):134-40. PubMed ID: 22301564
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current management of lupus nephritis.
    Houssiau FA; Lauwerys BR
    Best Pract Res Clin Rheumatol; 2013 Jun; 27(3):319-28. PubMed ID: 24238689
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sequential therapies for proliferative lupus nephritis.
    Yee CS; Gordon C
    N Engl J Med; 2004 Jun; 350(24):2518-20; author reply 2518-20. PubMed ID: 15190147
    [No Abstract]   [Full Text] [Related]  

  • 17. Mycophenolate mofetil for lupus nephritis.
    McCune WJ
    N Engl J Med; 2005 Nov; 353(21):2282-4. PubMed ID: 16306526
    [No Abstract]   [Full Text] [Related]  

  • 18. Updates on the treatment of lupus nephritis.
    Bomback AS; Appel GB
    J Am Soc Nephrol; 2010 Dec; 21(12):2028-35. PubMed ID: 21051743
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dutch guidelines for diagnosis and therapy of proliferative lupus nephritis.
    van Tellingen A; Voskuyl AE; Vervloet MG; Bijl M; de Sévaux RG; Berger SP; Derksen RH; Berden JH;
    Neth J Med; 2012 May; 70(4):199-207. PubMed ID: 22641632
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcomes in patients with active lupus nephritis requiring immunosuppressives who never received cyclophosphamide.
    Urowitz MB; Ibañez D; Ali Y; Gladman DD
    J Rheumatol; 2007 Jul; 34(7):1491-6. PubMed ID: 17610320
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.